REX AI Equity Premium Income ETF (NASDAQ: AIPI)

에 대한 최신 뉴스 REX AI Equity Premium Income ETF (NASDAQ:AIPI)

Technology

Real Estate

Consumer Cyclical

The fund invests at least 80% of its net assets (plus any borrowings for investment purposes) in securities comprising the BITA AI Leaders Select Index (the Index). The Fund is an actively managed exchange-traded fund (ETF) that seeks capital appreciation and current income while maintaining the opportunity for exposure to the share price (i.e., the price returns) of the securities of the companies comprising the Index, subject to a potential reduction in returns in a rising market.

Palantir Technologies Inc.

Arm Holdings Plc 0.00000000

Nvidia Corp.

Crowdstrike Holdings Inc. Class A

Datadog Inc. Class A

Arista Networks Inc.

ADOBE SYSTEMS INC

Broadcom Inc

Palo Alto Networks Inc.

International Business Machines Corp.

Meta Platforms, Inc.

Qualcomm Inc.

Synopsys Inc.

Alphabet Inc

Amazon.Com Inc

Super Micro Computer, Inc.

Apple Inc

Cisco Systems Inc

C3 Ai Inc A

Intel Corp.

Advanced Micro Devices Inc.

Servicenow, Inc.

Micron Technology, Inc.

REX AI Equity Premium Income ETF

alex karp palantir flickr2

Equities

News

Markets

ETFs

General

AIPI

ARKK

PLTR

SHLD

팔란티어 테크놀로지스(NASDAQ:PLTR)의 주가가 올해 초 대비 298.37% 상승하여 현재로서 주목받고 있다. 이 급등은 팔란티어에 상당한 노출을 가진 ETF에 대한 관심을 불러일으켰다.

팔란티어의 연간 수익률 급등 298%: 알렉스 카프의 회사에 노출된 ETF의 성과는?

palantir shutter

Long Ideas

Broad U.S. Equity ETFs

Tech

Trading Ideas

팔란티어 테크놀로지스(NYSE:PLTR)는 11월 26일부터 NYSE에서 나스닥 글로벌 선택 시장으로의 이전을 준비 중다. 이것이 향후 나스닥-100 지수 포함을 위한 한 단계가 될까?

나스닥 100 리밸런스가 다가오는 가운데 팔란티어에 노출을 갖는 고려해 볼 ETF 3가지

<a href="https://www.globenewswire.com/Tracker?data=GzwNc3MnbS_tvJZ1O4qMRvEi8V2fRFeS4ThyqxlfRvds7uCkqbbv8ZCvZTt7aUjbw0Cfg-hLntGJFQgJKpGQP0nd_0sQuDZWo1RBBLgWLnHcb884VT5-sIUR4BD_nU44Ibv307THBg1qxYqxir-QTeV0uNQR5jkjaFUGi4x938BBR-lPm_PMfhtU2U86JeLE40yUKdIIwYYp3KLmgrbXoJHwnrTmwZlSRo-ZkLn5bNN_NaHdVjPKX5PDGMUVMWHTimEvzRnCQbY-IuAkgLomgA==">Cue Biopharma, Inc.</a>&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CUE#NASDAQ">CUE</a>), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells for the treatment of autoimmune disease, today announced it has received Pre-Investigational New Drug (Pre-IND) feedback from the U.S. Food and Drug Administration (FDA). The FDA reviewed the first-in-human trial design, including the Company's plan for dose escalation, proposed populations and safety monitoring plan. On the basis of the FDA feedback, the Company, intends to file an IND pending completion of final IND enabling studies. CUE-401 is the Company's lead autoimmune asset, a first-in-class bispecific fusion protein/molecule designed to induce and expand regulatory T cells (Tregs) in vivo through the co-activity of transforming growth factor beta (TGF-β) and a modified variant of interleukin 2 (IL-2).

Biotech

Cue Biopharma Receives FDA Pre-IND Feedback For Lead Autoimmune Therapy CUE-401; Plans IND Filing Pending Final Studies

SMSI

Smith Micro Software Receives Nasdaq Minimum Bid Price Notice

Anterix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATEX#NASDAQ">ATEX</a>) reported quarterly losses of $(0.42) per share which beat the analyst consensus estimate of $(0.46) by 8.7 percent. This is a 17.65 percent increase over losses of $(0.51) per share from the same period last year. The company reported quarterly sales of $1.389 million which missed the analyst consensus estimate of $1.711 million by 18.80 percent. This is a 10.24 percent increase over sales of $1.260 million the same period last year.

Earnings

Earnings Beats

Earnings Misses

ATEX

Anterix Q4 Adj. EPS $(0.42) Beats $(0.46) Estimate, Sales $1.389M Miss $1.711M Estimate

ONEOK (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OKE#NYSE">OKE</a>) has outperformed the market over the past 5 years by 5.63% on an annualized basis producing an average annual return of 20.42%. Currently, ONEOK has a market capitalization of $50.32 billion. 
Buying $1000 In OKE: If an investor had bought $1000 of OKE stock 5 years ago, it would be worth $2,614.74 today based on a price of $80.56 for OKE at the time of writing.
<h3>ONEOK's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1750797921_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much You Would Have Made Owning ONEOK Stock In The Last 5 Years

FedEx Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FDX#NYSE">FDX</a>) reported financial results for the fourth quarter of fiscal 2025 after the market close on Tuesday. Here&#8217;s a rundown <a href="https://www.benzinga.com/pressreleases/25/06/b46082572/fedex-reports-fourth-quarter-diluted-eps-of-6-88-and-adjusted-diluted-eps-of-6-07">of the report</a>.
Q4 Earnings: FedEx reported fourth-quarter revenue of $22.2 billion, beating analyst&nbsp;<a href="http://benzinga.com/quote/FDX/earnings" target="_blank" rel="noreferrer noopener">estimates</a>&nbsp;of $21.84 billion, according to <a href="http://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>. The company reported fourth-quarter adjusted earnings of $6.07 per share, beating analyst estimates of $5.87 per share.
Operating results for the company&#8217;s Federal Express segment improved during the quarter, driven by cost reduction benefits. FedEx said its Freight segment operating results decreased in the quarter due to lower fuel surcharges, reduced weight per shipment, higher healthcare costs, increased wage rates and one fewer operating day.
FedEx returned $4.3 billion to shareholders in fiscal 2025 through repurchases and dividends. The company had $2.1 billion remaining under its buyback as of May 31.
&#8220;I am proud of the FedEx team for a solid finish to the fiscal year, delivering excellent service for our customers while achieving our structural cost reduction target, in the face of ongoing headwinds,&#8221; said Raj Subramaniam, president and CEO of FedEx.
&#8220;We will continue to leverage the unique scale and flexibility of our global network to support our customers as the demand environment evolves.&#8221;
Guidance: FedEx expects first-quarter adjusted earnings to be between $3.40 and $4 per share versus estimates of $4.15 per share. The company expects revenue to be flat to up 2% on a year-over-year basis in the first quarter.
FedEx is targeting permanent cost reductions of $1 billion from its DRIVE and Network 2.0 transformation programs in fiscal 2026. 
FedEx executives will further discuss the quarter on a conference call with investors and analysts at 5 p.m. ET.
FDX Price Action: <a href="http://benzinga.com/quote/fdx" target="_blank" rel="noreferrer noopener">FedEx shares</a> were down 4.40% in after-hours, trading at $219.41 at the time of publication on Tuesday, according to <a href="http://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/25/06/46018581/trumps-tariffs-trigger-layoffs-monopoly-maker-hasbro-slashes-jobs-these-companies-are-cutting-too">Trump&#8217;s Tariffs Trigger Layoffs: Monopoly Maker Hasbro Slashes Jobs — These Companies Are Cutting Too</a></li>
<li><a href="https://www.benzinga.com/news/financing/25/06/46066370/fred-smith-was-told-by-yale-professor-that-his-overnight-delivery-idea-would-only-earn-him-a-c-the-fedex-founder-turned-it-into-a-54-billion-logistics-giant">Fred Smith Was Told By Yale Professor That His Overnight-Delivery Idea Would Only Earn Him A &#8216;C&#8217; — The FedEx Founder Turned It Into A $54 Billion Logistics Giant</a></li>
</ul>
Photo: K.G. Yon/Shutterstock.

Guidance

After-Hours Center

Movers

FedEx Q4 Earnings: Revenue, EPS Beat Estimates, Shares Slide On Soft Guidance

OUTFRONT Media Announces Restructuring And Reduction In Force Plan; Plan To Reduce Workforce By About 120 Employees; Estimates $18.6M In Restructuring Charges

WIIM

FedEx shares are trading lower following soft Q1 guidance.

With President Donald Trump brokering a <a href="https://www.benzinga.com/news/politics/25/06/46072859/trump-says-israel-is-not-going-to-attack-iran-after-ceasefire-violation-turn-around-and-head-home">ceasefire between Israel and Iran</a>, the major indices have predictably swung higher. Still, this normalization shifts the fundamental spotlight back to the economy, where an underlying truth cannot be avoided: <a href="https://www.benzinga.com/news/25/04/44916124/frozen-pizza-sales-surge-like-2009-recession-as-americans-cut-back-on-dining-out-amid-economic-strain">many consumers are struggling</a> amid significant challenges. From a pragmatic perspective, this dynamic could benefit TJX Companies Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TJX#NYSE">TJX</a>). As an off-price department store, TJX specializes in the very discounts that consumers are looking for right now.
First, <a href="https://www.youtube.com/watch?v=dey0Q0MGmG8">statements</a> made by Federal Reserve Chair Jerome Powell to House lawmakers earlier today indicated that the central bank is in a wait-and-see mode. That's despite <a href="https://www.benzinga.com/news/politics/25/06/45898797/trump-and-jd-vance-push-fed-to-slash-interest-rates-after-mild-inflation-report-calling-current-policy-monetary-malpractice">increasing pressure from Trump</a> to implement rate cuts. However, Powell asserted that the Fed must fully understand the broader implications of the Trump administration's tariffs before initiating a change to monetary policy.
Reading between the lines, the central bankers are acknowledging the concerns of the consumer as it relates to costs of living. On a fundamental note, this circumstance may aid TJX stock due to the underlying discount retail business model.
Second, the specific catalyst that may help boost TJX is the <a href="https://www.benzinga.com/markets/options/25/06/45984657/kr-stock-trade-down-effect-earnings-reversal">trade-down effect</a>. This phenomenon refers to consumers, when faced with tough economic conditions, choosing to buy either less of a product or lower-cost alternatives. As I stated prior to the first-quarter earnings report of grocery giant Kroger Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KR#NYSE">KR</a>), this dynamic could help lift KR stock out of its then-slump.
It's worth pointing out that the actual print overall came in <a href="https://www.benzinga.com/analyst-stock-ratings/price-target/25/06/46059125/these-analysts-raise-their-forecasts-on-kroger-after-stronger-than-expected-q1-earnings">better than expected</a>, sending Kroger shares dramatically higher. With TJX <a href="https://www.benzinga.com/quote/TJX/earnings">reporting earnings in August</a>, investors will have to wait for a substantive driver. However, traders may be able to extract quick profits in the interim.
<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="1000" height="596" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/24151238/TJX-stock-technical-analysis.jpg" alt="" class="wp-image-960493" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/24151238/TJX-stock-technical-analysis.jpg 1000w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/24151238/TJX-stock-technical-analysis-300x179.jpg 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/24151238/TJX-stock-technical-analysis-768x458.jpg 768w" sizes="(max-width: 1000px) 100vw, 1000px" /><figcaption class="wp-element-caption">Image by TradingView</figcaption></figure>
From a technical viewpoint, there appears to be a resistance level at around $128. The idea here is that TJX stock could potentially hit this level within a few weeks, thus triggering an option strategy's profitability zone.
<h2 class="wp-block-heading">Using Statistical Analysis To Pinpoint A Strategy For TJX Stock</h2>
While both the fundamental and technical frameworks for TJX stock are arguably bullish, these methodologies only speak to the potential magnitude component of the underlying thesis or the price chart's y-axis. But with options trading, the x-axis is also critical; otherwise, the right thesis at the wrong time may still result in a complete loss of principal in a debit-based strategy.
To better understand the lay of the land, traders must view the problem probabilistically, which requires statistical analysis. At first glance, this process sounds easy: just take the frequency of the desired outcome divided by the total number of events in the dataset. However, this approach only calculates what's known as the derivative probability or the odds of an outcome across the dataset's entire distribution.
Unfortunately, derivative probabilities aren't very useful. For instance, air travel is statistically considered a safe form of travel but this insight is aggregated across the experiences of all flyers. If your pilot is inebriated or air traffic control employees are under extreme stress, the odds of something bad happening dramatically increase.
In other words, the probabilities that we're looking for is conditional. This refers to the odds of an outcome based off a specific subset of the data. But in order to extract conditional probabilities, the dataset (price action in this case) must be organized in discrete states to distinguish one state from another. Therefore, my metric of choice is market breadth — sequences of accumulative and distributive sessions.
Discrete states represent the <a href="https://brilliant.org/wiki/markov-chains/">backbone</a> of Markov chain analysis, which is the mathematical principle that I have been utilizing in the past few months. As it relates to TJX stock, the past two months' price action can be converted into discrete states under the sequencing format "4-6-U": four up weeks, six down weeks, with a net positive trajectory across the 10-week period.
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="576" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/24150858/TJX-stock-10wk-forecast-1024x576.jpg" alt="" class="wp-image-960487" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/24150858/TJX-stock-10wk-forecast-1024x576.jpg 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/24150858/TJX-stock-10wk-forecast-300x169.jpg 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/24150858/TJX-stock-10wk-forecast-768x432.jpg 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/24150858/TJX-stock-10wk-forecast.jpg 1280w" sizes="(max-width: 1024px) 100vw, 1024px" /><figcaption class="wp-element-caption">Image by author</figcaption></figure>
Admittedly, this process compresses the magnitude dynamism of TJX stock into a simple binary code. However, the benefit from a statistical standpoint is that the last-10-week intervals can be identified as unique behavioral states. Using past analogs, we can determine that when the 4-6-U sequence flashes, there's a 63.64% chance that the following week's price action results in upside, with a median return of 2.28%.
Projecting an upside target isn't an exact science due to the market's usual chaos. However, if the bulls maintain control of the market, a rational target is $128.20 over the next three to four weeks — roughly aligning with the aforementioned resistance level.
<h2 class="wp-block-heading">A Bold Debit Call Spread For The Risk-Tolerant Speculator</h2>
For traders interested in rolling the mathematical dice, the 127/128 bull call spread expiring July 18 may be tempting. This transaction involves buying the $127 call and simultaneously selling the $128 call, for a net debit paid of $46 (the most that can be lost in the trade). Should TJX stock rise through the short strike price ($128) at expiration, the maximum reward is $54, a payout of over 117%.
What makes this trade so enticing is the implied shift in sentiment regime of the 4-6-U sequence. As a baseline, the chance that TJX stock may rise over any given week is 54.11%. Therefore, the aforementioned sequence boosts the bullish odds quite significantly. In other words, the call spread may be favorably mispriced.
Part of the reason for the mispricing is that the vast majority of Wall Street analysts rely on interpretations of non-stationary price signals or financial ratios. Generally, these interpretations are vague, presenting difficulties for traders. With the above discrete-state analysis, we're using math and science to help pinpoint our strategic framework.
The opinions and views expressed in this content are those of the individual author and do not necessarily reflect the views of Benzinga. Benzinga is not responsible for the accuracy or reliability of any information provided herein. This content is for informational purposes only and should not be misconstrued as investment advice or a recommendation to buy or sell any security. Readers are asked not to rely on the opinions or information herein, and encouraged to do their own due diligence before making investing decisions.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/options/25/06/46061830/crwd-stock-gains-relevance-iran-cyberattack-threat">Options Corner: CrowdStrike Gains Relevance As Iran Poses Cyber Retaliation Threat</a></li>
</ul>
Photo: Shutterstock

Options

Politics

Events

Options Corner: TJX Companies May Be Poised For Upside As Shoppers Hunt For Discounts

QuantumScape shares are trading higher after the company achieved a key 2025 milestone by successfully integrating its advanced Cobra separator process into baseline cell production.

Mirion Technologies shares are trading higher after the company announced a partnership with Westinghouse to provide digital Ex-core Nuclear Instrumentation Systems.

Macro Economic Events

Econ #s

Economics

UPDATE: USA API Weekly Crude Oil Stock 4.277M Barrel Draw Vs 600K Barrel Draw Est

<a href="https://www.bloomberg.com/news/articles/2025-06-24/best-buy-divests-home-care-unit-bought-for-400-million-in-2021?embedded-checkout=true">https://www.bloomberg.com/news/articles/2025-06-24/best-buy-divests-home-care-unit-bought-for-400-million-in-2021?embedded-checkout=true</a>

'Best Buy Divests Home Care Unit Bought for $400 Million in 2021'- Bloomberg

Anterix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATEX#NASDAQ">ATEX</a>) reported quarterly sales of $1.39 million which missed the analyst consensus estimate of $1.71 million by 18.80 percent. This is a 10.24 percent increase over sales of $1.26 million the same period last year.

Anterix Q4 Sales $1.39M Miss $1.71M Estimate

Achieves Key 2025 Goal, Bringing its Technology Closer to Commercialization
<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.quantumscape.com%2F&amp;esheet=54281769&amp;newsitemid=20250624801952&amp;lan=en-US&amp;anchor=QuantumScape+Corporation&amp;index=1&amp;md5=f56eb983a9f8bd5b586e236b4698c776">QuantumScape Corporation</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QS#NYSE">QS</a>), a global leader in next-generation solid-state lithium-metal battery technology, today announced a major milestone in the scale-up of its production capabilities: the successful integration of its advanced <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fyoutu.be%2FoJgoe_CHTKM&amp;esheet=54281769&amp;newsitemid=20250624801952&amp;lan=en-US&amp;anchor=Cobra+separator+process&amp;index=2&amp;md5=81007103950141134d8b7020fa8678e8">Cobra separator process</a> into baseline cell production.
Cobra forms the foundation of QS's high-throughput, continuous-flow separator production platform. Designed to enable faster, more energy-efficient production with a smaller equipment footprint compared to earlier processes, Cobra represents a step-change improvement in ceramic separator manufacturing. Compared to the prior-generation Raptor process, Cobra offers a ~25x improvement in heat treatment speed and occupies a fraction of the physical space per film start – key advantages in the design of a scalable gigafactory production line.

QuantumScape Achieves Key 2025 Milestone In The Scale-Up Of Its Production Capabilities With The Successful Integration Of Its Advanced Cobra Separator Process Into Baseline Cell Production

RKLB

Rocket Lab Announces 'Get The Hawk Outta Here' Mission Launch Window Opens Jun. 26 At 17:00 UTC

Management

JACK

Jack In The Box's Shannon McKinney Returns As Senior Vice President And COO

Superior Industries International Receives NYSE Notice For Non-Compliance With Listing Rules

Canadian Natural Res (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNQ#NYSE">CNQ</a>) has outperformed the market over the past 5 years by 14.5% on an annualized basis producing an average annual return of 29.29%. Currently, Canadian Natural Res has a market capitalization of $65.98 billion. 
Buying $1000 In CNQ: If an investor had bought $1000 of CNQ stock 5 years ago, it would be worth $3,686.55 today based on a price of $31.52 for CNQ at the time of writing.
<h3>Canadian Natural Res's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1750797029_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much You Would Have Made Owning Canadian Natural Res Stock In The Last 5 Years

<h3>GAINERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/CANN">Trees</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CANN#OTC">CANN</a>) shares closed up 124.58% at $0.02</li>
<li><a href="https://www.benzinga.com/quote/FFNTF">4Front Ventures</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FFNTF#OTC">FFNTF</a>) shares closed up 100.00% at $0.0002</li>
<li><a href="https://www.benzinga.com/quote/PHOT">GrowLife</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/PHOT#OTC">PHOT</a>) shares closed up 100.00% at $0.0004</li>
<li><a href="https://www.benzinga.com/quote/BLGVF">Belgravia Hartford Cap</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BLGVF#OTC">BLGVF</a>) shares closed up 47.20% at $0.26</li>
<li><a href="https://www.benzinga.com/quote/CVSI">CV Sciences</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CVSI#OTC">CVSI</a>) shares closed up 28.95% at $0.04</li>
<li><a href="https://www.benzinga.com/quote/KAYS">Kaya Holdings</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/KAYS#OTC">KAYS</a>) shares closed up 14.37% at $0.04</li>
<li><a href="https://www.benzinga.com/quote/CURR">Currenc Group</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CURR#NASDAQ">CURR</a>) shares closed up 13.28% at $0.56</li>
<li><a href="https://www.benzinga.com/quote/TGIFF">1933 Industries</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TGIFF#OTC">TGIFF</a>) shares closed up 13.16% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/ITHUF">iAnthus Capital Hldgs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ITHUF#OTC">ITHUF</a>) shares closed up 8.51% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/XXII">22nd Century Group</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XXII#NASDAQ">XXII</a>) shares closed up 7.89% at $7.25</li>
<li><a href="https://www.benzinga.com/quote/CLSH">CLS Holdings USA</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CLSH#OTC">CLSH</a>) shares closed up 7.55% at $0.04</li>
<li><a href="https://www.benzinga.com/quote/MGWFF">Maple Leaf Green World</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/MGWFF#OTC">MGWFF</a>) shares closed up 6.52% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/YCBD">cbdMD</a> (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/YCBD#AMEX">YCBD</a>) shares closed up 6.15% at $0.88</li>
<li><a href="https://www.benzinga.com/quote/TLRY">Tilray Brands</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>) shares closed up 6.10% at $0.38</li>
<li><a href="https://www.benzinga.com/quote/TCNNF">Trulieve Cannabis</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TCNNF#OTC">TCNNF</a>) shares closed up 4.28% at $3.41</li>
<li><a href="https://www.benzinga.com/quote/OGI">Organigram Global</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OGI#NASDAQ">OGI</a>) shares closed up 3.13% at $1.36</li>
<li><a href="https://www.benzinga.com/quote/CNTMF">FLUENT</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNTMF#OTC">CNTMF</a>) shares closed up 3.09% at $0.05</li>
</ul>
<h3>LOSERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/LMLLF">Pharmadrug</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LMLLF#OTC">LMLLF</a>) shares closed down 21.84% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/MXC">Mexco Energy</a> (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MXC#AMEX">MXC</a>) shares closed down 14.39% at $9.72</li>
<li><a href="https://www.benzinga.com/quote/CBDY">Target Group</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CBDY#OTC">CBDY</a>) shares closed down 13.04% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/BBRRF">Blueberries Medical</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BBRRF#OTC">BBRRF</a>) shares closed down 12.62% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/CNBX">CNBX Pharmaceuticals</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNBX#OTC">CNBX</a>) shares closed down 9.09% at $0.001</li>
<li><a href="https://www.benzinga.com/quote/ZDPY">Zoned Properties</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ZDPY#OTC">ZDPY</a>) shares closed down 6.81% at $0.52</li>
<li><a href="https://www.benzinga.com/quote/OILFF">Nextleaf Solutions</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/OILFF#OTC">OILFF</a>) shares closed down 4.37% at $0.05</li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Cannabis

BBRRF

BLGVF

CANN

CBDY

CLSH

CNBX

CNTMF

CURE PHARMA HLDG CORP by CURE Pharmaceutical Holding Corp.

CURR

CVSI

FFNTF

ITHUF

KAYS

LMLLF

MGWFF

OILFF

PHOT

TCNNF

TGIFF

TLRY

XXII

YCBD

ZDPY

Bullish Sentiment Across The Cannabis Space - Check Full Movers For June 24, 2025

FBRX

Forte Biosciences shares are trading lower after the company announced a proposed public offering.

Press Releases

REX Shares Unveils Latest Covered Call ETF Designed to Enhance Exposure to Crypto Leaders

REX Financial Unveils the REX NVDA Growth & Income ETF, the First Fund in New Single Stock Covered Call ETF Suite

CEPI

FEPI

팔란티어 테크놀로지스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>)의 주가가 올해 초 대비 298.37% 상승하여 현재로서 주목받고 있다. 이 급등은 팔란티어에 상당한 노출을 가진 ETF에 대한 관심을 불러일으켰다.
<a href="https://pro.benzinga.com/" target="_blank" rel="noopener">벤징가 프로</a>에 따르면, Global X Defense Tech ETF(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHLD#NYSE">SHLD</a>)는 포트폴리오의 7.82%를 팔란티어 주식에 투자하여 약 5,185만 달러에 해당하는 124만 주를 보유하고 있다. SHLD는 팔란티어의 방산 및 정보 분야 존재와 다른 항공우주 및 방산 기업들을 결합한 ETF로, 올해 초 대비 40.86% 상승한 실적을 기록했다.
한편, ARK Innovation ETF(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARKK#NYSE">ARKK</a>)는 포트폴리오의 거의 5%를 팔란티어에 할당하여 2억 7,300만 달러 이상을 653만 주에 투자했다. 고성장 기업들을 지원하는 것으로 알려진 ARKK는 60억 달러 이상의 운용 자산을 보유하고 있으며, 올해 초 대비 13.17% 상승한 실적을 기록했다.
반면, REX AI Equity Premium Income ETF(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIPI#NASDAQ">AIPI</a>)는 팔란티어에 9.46% 노출되어 있으며, 924만 달러 규모의 포지션을 가지고 있다. 그러나 AIPI의 올해 초 대비 수익률은 0.61% 감소했다. AIPI는 아웃 오브 더 머니 커버드 콜 옵션을 매도하여 수익을 창출하지만, 자본 증가를 제한할 수 있는 전략을 사용한다.
작성 시점에 팔란티어의 주가는 수요일 정규 거래에서 0.47% 오른 66.05달러에 마감했다. 이후 시간외 거래에서 0.23% 상승했다. 최근 분석가들의 팔란티어에 대한 평가가 BofA 증권, 웨드부시 및 골드만삭스에 의해 각각 11월 25일과 11월 7일에 발행되었으며, 이들 기관의 평균 목표 주가가 63.67달러로 설정되었다.
<img decoding="async" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/28083739/Screenshot-2024-11-28-at-7.07.26%E2%80%AFPM-1024x390.png?optimize=medium&amp;dpr=1.25&amp;auto=webp&amp;width=2048" />
면책 조항: 이 콘텐츠는 <a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener" data-google-interstitial="false">Benzinga Neuro</a>의 도움으로 부분적으로 제작되었으며 Benzinga 편집자가 검토하고 게시했습니다.
Image via Flickr
다른 트레이더들보다 30분 일찍 독점 시장 움직임 뉴스를 받아보세요. 
Benzinga Pro의 14일 무료 체험을 통해 독점 뉴스 기사를 이용할 수 있어 수백만 명의 다른 트레이더보다 먼저 실행 가능한 거래 뉴스를 얻을 수 있습니다. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

팔란티어 테크놀로지스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NYSE">PLTR</a>)는 11월 26일부터 <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/11/42014351/palantir-prepares-nasdaq-move-could-nasdaq-100-be-next">NYSE에서 나스닥</a> 글로벌 선택 시장으로의 이전을 준비 중다.
이것이 향후 나스닥-100 지수 포함을 위한 한 단계가 될까?
투자자들은 이 주식의 상장지수펀드(ETF) 노출에 주목하고 있으며, 특히 나스닥-100 포함 가능성으로 인해 가시성과 시장 가치가 상승함에 따라 주목하고 있다.
또한 읽어보세요: <a href="https://www.benzinga.com/24/11/42094248/trumps-return-boosts-palantir-national-security-bets-drive-140-billion-market-cap">팔란티어 테크의 1,400억 달러 시가총액 증가가 트럼프의 승리와 국방비 증가 기대에 의해 주도 &#8211; 주식이 고평가되었나?</a>
PLTR 주식에 대한 확고한 노출을 가진 세 가지 ETF를 소개한다. 우리는 투자자들이 고려할 수 있는 적절한 노출과 좋은 유동성을 제공할 수 있는 ETF를 선택했다.
<h3 class="wp-block-heading">REX AI Equity Premium Income ETF(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIPI#NASDAQ">AIPI</a>)</h3>
AIPI 포트폴리오는 PLTR 주식에 9.46% 노출되어 있으며, 이는 팔란티어에 대한 924만 달러의 포지션으로 환산된다. 이 ETF는 로봇공학과 인공지능(AI)에 중점을 두고 있으며, 이는 팔란티어의 기술 주도 솔루션과 잘 맞아떨어진다.
상당한 노출로 인해 AIPI는 팔란티어의 성장 잠재력에 대한 강력한 베팅을 제공한다. ETF의 25.38억 달러 AUM(운용 자산)으로 인해 적절한 유동성을 보장한다.
<h3 class="wp-block-heading">Global X Defense Tech ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHLD#NYSE">SHLD</a>)</h3>
SHLD 포트폴리오는 PLTR 주식에 7.82% 노출되어 있어, 다양한 방산 기술 ETF를 찾는 투자자들에게 적절한 비율이다. 이 ETF는 팔란티어의 방산 및 정보 분야의 존재와 항공우주 및 방산의 기타 주요 플레이어들을 결합한다.
430.87백만 달러의 AUM을 보유한 이 펀드는 유동성을 잘 유지하면서 투자자들에게 안정적인 팔란티어 주식의 일부를 제공한다.
<h3 class="wp-block-heading">ARK Innovation ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARKK#NYSE">ARKK</a>)</h3>
팔란티어는 ARKK에서도 두각을 나타내며, 포트폴리오의 거의 5%를 PLTR 주식에 할당했다. 2억 7,300만 달러 이상이 팔란티어 주식에 투자된 653만 주를 보유하고 있는 ARKK는 혁신 분야에서 강한 위력을 발휘하며 고성장 기업을 지원하는 것으로 알려져 있다. 이 펀드는 60억 달러 이상의 AUM을 보유하여 투자 유동성을 보장한다.
팔란티어에 대한 노출은 기술 중심의 포트폴리오에 적절히 맞아떨어지며, 이 ETF의 규모와 유동성은 팔란티어의 미래 잠재력에 투자하려는 투자자들에게 여전히 유효한 옵션이 된다.
팔란티어가 나스닥 상장과 나스닥-100 편입 가능성에 가까워짐에 따라, 이러한 ETF들은 투자자들에게 회사에 대한 노출을 얻을 수 있는 기회를 제공한다.
상당한 PLTR 주식 노출과 강력한 유동성을 가진 이 펀드들은 팔란티어의 잠재적 성장에 투자하려는 이들에게 스마트한 선택이 될 수 있다.

다음 읽어보기:
<ul>
<li><a href="https://www.benzinga.com/general/market-summary/24/11/42058235/palantir-board-member-in-a-deleted-x-post-said-nasdaq-move-will-force-billions-in-etf-buying-and-deliver-tendies-heres-what-this-meme-stock-term-means">팔란티어 이사회 위원이 삭제된 X 포스트에서 나스닥 이동이 &#8216;수십억 달러의 ETF 매수를 강요하고, 텐디를 제공할 것&#8217;이라고 말했다. 이 밈 주식 용어의 의미는 무엇인가?</a></li>
</ul>
이미지: Shutterstock
다른 트레이더들보다 30분 일찍 독점 시장 움직임 뉴스를 받아보세요. 
Benzinga Pro의 14일 무료 체험을 통해 독점 뉴스 기사를 이용할 수 있어 수백만 명의 다른 트레이더보다 먼저 실행 가능한 거래 뉴스를 얻을 수 있습니다. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

Comments

REX AI Equity Premium Income ETF

뉴스

에 대한 최신 뉴스 REX AI Equity Premium Income ETF (NASDAQ:AIPI)

금요일, 11월 29, 2024

토요일, 11월 23, 2024

뉴스

파트너 / 기고자

벤징가 글로벌